ghk-cu injection safety human study Regenerative and Protective Actions of the Peptide in the Light of the New Gene Data I stopped by @the_atlanta_aesthetician to
Description
As of today, there are no large-scale, double-blind, placebo-controlled human trials specifically investigating BPC 157 for herniated discs
RW F, Meeker AD, Cady PS, Culbertson VL, Force WS, Kelley CM
Its structure is a continuous escalation-then-maintenance arc: Initiation phase (weeks 14): 2.5 mg weekly
Repeat: patients typically run 2 full cycles per year on this protocol
